Mr Alan Whitmore

Chief Scientific Officer at Tangram Therapeutics

Speaker

Alan Whitmore, BM, BCh, PhD, MRCGP, FFPM is the Chief Scientific Officer of Tangram Therapeutics , where he has been instrumental in the conception, design, implementation and development of the ETX computational drug discovery platform and its deployment into GalNAc-siRNA drug discovery and development. He is a clinician-scientist with over 30 years’ experience in cell and computational biology research, drug discovery and clinical medicine and has held a variety of roles including MRC Fellow, UCL Laboratory for Molecular Cell Biology; Visiting Fellow, The Jackson Laboratory, US; and Hon Senior Lecturer, UCL School of Pharmacy, as well as senior clinical management positions.